This newsletter activity highlights some of the new concepts reshaping the approaches to the treatment of patients with diabetes mellitus that were presented at the American Diabetes Association 75th Scientific Sessions held in Boston, Massachusetts, June 5-9, 2015. Guest editors Martin Abrahamson, MD, and Timothy Reid, MD, provide insights into selected sessions and posters related to medications, patient self-management, and clinical practice. The newsletter focuses on new and evolving basal insulin analogs, as well as new evidence concerning the cardiovascular safety of incretin-based therapy. Strategies are also presented to provide and engage the patient in diabetes education. Finally, different models for providing patient care, including greater involvement of non-physicians, and their impact on patients are presented.

Faculty

Martin J. Abrahamson, MD
Associate Professor of Medicine
Boston, Massachusetts

Timothy Reid, MD
Medical Director, Mercy Diabetes Center
Department of Family Medicine
Janesville, Wisconsin

Target audience

This activity was developed for endocrinologists, primary care physicians, and other health care providers who treat patients with type 1 and type 2 diabetes.

Learning objectives

At the conclusion of this activity, participants should be better able to:

• Review the latest data on the treatment of type 1 and type 2 diabetes
• Discuss how new diabetes data, treatments, and/or recommendations can impact clinical practices to improve diabetes

Instructions

You may participate by reading the newsletter and completing the post test, "Quiz" questions. When ready to claim your CME credit, click on and complete the "Program Evaluation" first (required) and then click on "Certificate" to receive your certificate. 

This activity is supported by an independent educational grant from sanofi-aventis U.S.